| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 50.429 | 50 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.7437 | 44 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.7895 | 53 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.5994 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.4086 | 46 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.2094 | 28 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 55.1513 | 60 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 49.0616 | 45 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.6864 | 35 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.2679 | 33 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.849 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.7372 | 48 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.5049 | 20 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.4272 | 39 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.4314 | 39 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 51.1495 | 52 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.2933 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 51.6997 | 53 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.2175 | 14 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.0483 | 18 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 51.5229 | 53 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.6602 | 40 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 44.4292 | 24 |